openPR Logo
Press release

Acute Lymphoblastic Leukemia Market 2019 Analysis May Set New Growth Story, Forecast to 2025

12-29-2020 08:58 AM CET | Health & Medicine

Press release from: Orion Market Research

Acute Lymphoblastic Leukemia Market 2019 Analysis May Set New

The global acute lymphoblastic leukemia market is growing at a significant CAGR during the forecast period. One of the major factors that are driving the global acute lymphoblastic leukemia market is the growing number of patients of acute lymphoblastic leukemia. According to the Leukemia & Lymphoma Society, approximately every 3 minutes one person in the United States (US) is diagnosed with blood cancer. Further, an estimated combined total of 176,200 people in the US is expected to be diagnosed with leukemia, lymphoma or myeloma in 2019. In addition, new cases of leukemia, are expected to account for 10% of the estimated 1,762,450 new cancer cases diagnosed in the US in 2019 making a huge opportunity for new as well as established market players in the region.

Request a Free Sample of our Acute Lymphoblastic Leukemia Market: https://www.omrglobal.com/request-sample/acute-lymphoblastic-leukemia-market

Acute lymphoblastic leukemia is a blood cancer that begins in the bone marrow and quickly spreads to the blood. It is one of the four main leukemia types.It requires early intervention as it is a very aggressive disease. Many acute-leukemia patients would only survive for a couple of months without treatment. In children under five years of age, acute lymphoblastic leukemia is most common. Additionally, targeted therapy is one of the most chosen therapies owing to several benefits associated with it including target-specific act and its capability of preventing collateral damage that leads to faster recovery, hence it is one of the major factors augmenting the market growth.

The rising essentiality of chemotherapy is additionally contributing to market growth. According to the American Cancer Association chemotherapy is the chief treatment for the patients that are suffering from acute lymphoblastic leukemia. Cytotoxic drugs are being used in chemotherapy for cell destruction, further, according to India pediatrics chemotherapy treatment is a most trusted treatment for any cancer type and is decreasing the rate of mortality rate in the country, hence it is contributing to the market growth as well. Further, increasing technological advancement and the launch of new products and drugs are assisting in market growth. However, the high cost of treatments and low disposable income in developing economies is expected to hinder the growth of the market

A full Report of Acute Lymphoblastic Leukemia Market is Available at: https://www.omrglobal.com/industry-reports/acute-lymphoblastic-leukemia-market

The key market players that are dominating the global acute lymphoblastic leukemia market include Pfizer, Inc., Spectrum Pharmaceuticals Inc., Novartis AG, Hoffmann La Roche Ltd., Celgene Corp., Thermo Fisher Scientific, Inc., Eli Lilly & Co., Lonza Group Ltd., and many others.Geographical expansion, merger & acquisition, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopt and ed by major market players. For instance, in June 2019 Bristol-Myers Squibb Company partnered with QIAGEN to utilize NGS technology, this partnership was primarily carried out to produce gene expression profiles to be used in immune-oncology therapies.

Global Acute Lymphoblastic Leukemia - Segment

By Cell Type

• B-Cell
• T-Cell

By Treatment

• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Immunotherapy
• Stem Cell Transplantation

By End-User

• Hospitals and Clinics
• Research Institutes
Global Acute Lymphoblastic Leukemia – Regional

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• CompanyProfiles
AbbVie, Inc.
AdaptiveBiotechnologiesCorp.
Amgen, Inc.
AstraZenecaPLCInc.
Athenex, Inc.
BaxterInternational, Inc.
BlubirdBio, Inc.
Bristol-MyersSquibbCo.
CabalettaBio, Inc.
CARsgenTherapeuticsCo. Ltd.
CelgeneCorp.
DaiichiSankyoCo. Ltd.
DecipheraPharmaceuticalsLLC
EisaiCoLtd.
EliLillyandCo
ErytechPharma, SA
F. Hoffmann-LaRocheLtd.
FormulaPharmaceuticals, Inc.
GamidaCellLtd.
GenmabA/S
ImmunoGenInc.
JunoTherapeutics, Inc.
KitePharma, Inc.
LonzaGroupLtd.
MedigeneAG
NexImmuneInc.
NimbusTherapeuticsInc.
NohlaTherapeutics, Inc.
Protheragen, Inc.
SpectrumPharmaceuticals, Inc.
TakedaPharmaceuticalCo. Ltd.
Thermo Fisher Scientific, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/acute-lymphoblastic-leukemia-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Lymphoblastic Leukemia Market 2019 Analysis May Set New Growth Story, Forecast to 2025 here

News-ID: 2218231 • Views:

More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for Leukemia

The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market …
The Leukemia Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Leukemia Therapeutics Market Size During the Forecast Period? In recent times, the market size for leukemia therapeutics has seen robust growth. It is projected to increase from $17.57 billion in 2024
Leukemia Therapeutics Market - Revolutionizing Leukemia Care: Cutting-Edge Thera …
Newark, New Castle, USA: The "Leukemia Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Leukemia Therapeutics Market: https://www.growthplusreports.com/report/leukemia-therapeutics-market/7759 This latest report researches the industry structure, sales, revenue,
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to